Lupin rises on getting tentative approval for Ivacaftor Tablets from USFDA

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 612.10, up by 2.20 points or 0.36% from its previous closing of Rs. 609.90 on the BSE. The scrip opened at Rs. 607.00 and has touched a high and low of Rs. 614.60 and Rs. 603.00 respectively. So far 89358 shares were traded on the counter. The BSE group … Read more